New JAMA Study Shows Tongxinluo Improves Outcomes for STEMI Heart Attack Patients
A recent study published in JAMA reveals that Tongxinluo, a Traditional Chinese Medicine, can significantly improve outcomes in patients suffering from ST-elevation myocardial infarction (STEMI) when used alongside standard care. Learn how this compound can reduce the risk of major adverse events in heart attack patients.